Suofu Qin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Induced Pluripotent Stem Cells

Placebo Controlled

Top Venues

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)